Zobrazeno 1 - 7 of 7 pro vyhledávání: '"Alberi Adolfo Feltrin"'
1
Akademický článek
Leuprorrelina versus Gosserrelina no tratamento de câncer de próstata avançado: estudo de custo minimização
Autor: Letícia Viatroski Carvalho, Alberi Adolfo Feltrin, Rafael José Vargas Alves, Karin Hepp Schwambach, Carine Raquel Blatt
Publikováno v: Jornal de Assistência Farmacêutica e Farmacoeconomia, Vol 4, Iss 3 (2022)
Objetivo: Realizar uma avaliação de custo-minimização, comparando os medicamentos gosserrelina e leuprorrelina no tratamento do câncer de próstata avançado em um hospital público de Porto Alegre, RS. Métodos: Estudo retrospectivo com dados s
Externí odkaz: https://doaj.org/article/3744f56d00f547c881673bf516559078
Zobrazit plný text záznamu
2
Akademický článek
Effectiveness and safety of protease inhibitors for the hepatitis C treatment in a hospital of South Brazil: real life data
Autor: Aline Bianca Borba Mattana, Karin Hepp Schwambach, Alberi Adolfo Feltrin, Mareni Rocha Farias, Carine Raquel Blatt
Publikováno v: Revista de Ciências Farmacêuticas Básica e Aplicada, Vol 39, Pp 1-7 (2020)
Introduction: The combination of Inhibitors of protease boceprevir (BOC) or telaprevir (TLV) concomitantly with peginterferon (PEG) and ribavirin (RBV) constitute the triple therapy (TT) for Hepatitis C treatment. Objective: To describe the experienc
Externí odkaz: https://doaj.org/article/f18325ec98154c5f80704333d46d8acc
Zobrazit plný text záznamu
3
Akademický článek
Hepatitis C in Brazil: lessons learned with boceprevir and telaprevir
Autor: Lenyta Oliveira Gomes, Marina Rodrigues Teixeira, Júnior André da Rosa, Alberi Adolfo Feltrin, João Paulo V. Rodrigues, Mariane D’Avila Vecchi, Jane Meire M. Carneiro, Lúcia de Araújo C. B. Noblat, Silvana Gama F. Chachá, Ana de Lourdes C. Martinelli, Leonardo Regis L. Pereira, Marysabel Pinto T. Silveira, Carine Raquel Blatt, Mareni Rocha Farias
Publikováno v: Revista do Instituto de Medicina Tropical de São Paulo, Vol 60, Iss 0 (2018)
ABSTRACT In 2012, the first-generation protease inhibitors telaprevir (TVR) and boceprevir (BOC) were introduced in the Brazilian health system for treatment of chronic hepatitis C, after their approval by the National Committee for Health Technology
Externí odkaz: https://doaj.org/article/9d02ad81afa6421089067f67acde4271
Zobrazit plný text záznamu
4
Akademický článek
IMPACT OF THE PEGYLATED-INTERFERON AND RIBAVIRIN THERAPY ON THE TREATMENT-RELATED MORTALITY OF PATIENTS WITH CIRRHOSIS DUE TO HEPATITIS C VIRUS
Autor: Kelly Fernanda Nomura DRESCH, Angelo Alves de MATTOS, Cristiane Valle TOVO, Fernanda Quadros de ONOFRIO, Leandro CASAGRANDE, Alberi Adolfo FELTRIN, Iago Christofoli de BARROS, Paulo Roberto Lerias de ALMEIDA
Publikováno v: Revista do Instituto de Medicina Tropical de São Paulo, Vol 58, Iss 0 (2016)
Although the protease inhibitors have revolutionized the therapy of chronic hepatitis C (CHC), the concomitant use of pegylated-interferon (PEG-IFN) and ribavirin (RBV) is associated to a high rate of adverse effects. In this study, we evaluated the
Externí odkaz: https://doaj.org/article/cced8d7de68447fa82e061c9adb6aacf
Zobrazit plný text záznamu
5
Antiretroviral therapy does not affect response to chronic hepatitis C therapy in HIV-coinfected patients
Autor: Dimas Alexandre Kliemann, Cristiane Valle Tovo, Liliane Souto Pacheco, Paulo Roberto Lerias de Almeida, Alberi Adolfo Feltrin, Luciana Brosina de Leon, Angelo Alves de Mattos
Publikováno v: The Journal of Infection in Developing Countries. 10:762-769
Introduction: Many patients coinfected with the human immunodeficiency virus (HIV) and hepatitis C virus (HCV) are using highly active antiretroviral therapy (HAART) and HCV therapy with peginterferon (PEG-IFN) and ribavirina (RBV) because the use of
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88ff814d0f3a83e26912ea1c8673c892
https://doi.org/10.3855/jidc.7542
Zobrazit plný text záznamu
6
Hepatitis C in Brazil: lessons learned with boceprevir and telaprevir
Autor: Lúcia de Araújo Costa Beisl Noblat, Júnior André da Rosa, João Paulo Vilela Rodrigues, Ana de Lourdes Candolo Martinelli, Marysabel Pinto Telis Silveira, Lenyta Oliveira Gomes, Mariane D Ávila Vecchi, Silvana Gama Florencio Chachá, Marina Rodrigues Teixeira, Leonardo Régis Leira Pereira, Mareni Rocha Farias, Carine Raquel Blatt, Alberi Adolfo Feltrin, Jane Meire M. Carneiro
Publikováno v: Revista do Instituto de Medicina Tropical de São Paulo; Vol. 60 (2018); e29
Revista do Instituto de Medicina Tropical de São Paulo; v. 60 (2018); e29
Revista do Instituto de Medicina Tropical de São Paulo
Instituto de Medicina Tropical (IMT)
instacron:IMT
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Revista do Instituto de Medicina Tropical de São Paulo, Volume: 60, Article number: e29, Published: 28 JUN 2018
Revista do Instituto de Medicina Tropical de São Paulo, Vol 60, Iss 0 (2018)
In 2012, the first-generation protease inhibitors telaprevir (TVR) and boceprevir (BOC) were introduced in the Brazilian health system for treatment of chronic hepatitis C, after their approval by the National Committee for Health Technology Incorpor
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::483ea6dd53865c31215b795f2459d7cd
https://www.revistas.usp.br/rimtsp/article/view/148079
Zobrazit plný text záznamu
7
Terapia tripla em pacientes com hepatite C: experiência inicial em um pólo de aplicação do Sul do Brasil
Autor: Vivian W Koch, Carla Bortolin Fonseca, Alberi Adolfo Feltrin, Amanda M Souza, Cristiane Valle Tovo, Paulo Roberto Lerias de Almeida
Publikováno v: Arquivos de Gastroenterologia, Vol 52, Iss 1, Pp 14-17 (2015)
Arquivos de Gastroenterologia v.52 n.1 2015
Arquivos de gastroenterologia
Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia
instacron:IBEPEGE
Arquivos de Gastroenterologia, Volume: 52, Issue: 1, Pages: 14-17, Published: MAR 2015
Background Chronic hepatitis C has great impact on world’s health. Current therapy for genotype 1 hepatitis C virus includes protease inhibitors boceprevir and telaprevir, associated to standard therapy - peginterferon alfa + ribavirin. There are n
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::159db23307514346082ad29b0e84d66d
https://pubmed.ncbi.nlm.nih.gov/26017076
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje